This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...